(Q46832264)

25 December 2017

title

Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome (English)

1 reference

25 December 2017

1 reference

Gabriela de Larrañaga

1

1 reference

25 December 2017

Silvia Perés Wingeyer

2

1 reference

25 December 2017

Mabel Graffigna

3

1 reference

25 December 2017

Susana Belli

4

1 reference

25 December 2017

Karla Bendezú

5

1 reference

25 December 2017

Silvia Alvarez

6

1 reference

25 December 2017

Oscar Levalle

7

1 reference

25 December 2017

Hugo Fainboim

8

1 reference

25 December 2017

publication date

26 December 2007

1 reference

25 December 2017

Clinical and Applied Thrombosis-Hemostasis

published in

1 reference

25 December 2017

volume

14

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

319-324

1 reference

25 December 2017

cites work

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

PAI-1 and the metabolic syndrome: links, causes, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Obesity, Metabolic Syndrome, and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Silent non-alcoholic fatty liver disease-a clinical-histological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Pleiotropic functions of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Hepatic steatosis and insulin resistance: does etiology make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029607304094

release_ndj4t3d4ivatbiubaf72nibzly

21 January 2018

Identifiers

DOI

10.1177/1076029607304094

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ndj4t3d4ivatbiubaf72nibzly

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017